Test Price
2,800 AED✅ Home Collection Available
PALB2 Gene Pancreatic Cancer Susceptibility (Genetic Test) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل PALB2 للاستعداد لسرطان البنكرياس في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Grade Certainty & Patient‑Centric Logistics
- ✓99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited NGS processing, ensuring every PALB2 pathogenic variant is detected with unmatched precision.
- ✓Premium Hospital‑Grade Home Collection – ISO‑certified cold‑chain phlebotomy, VIP nurse visit (8 AM‑11 PM) for whole blood or FTA card samples.
- ✓Telephonic Post‑Test Clinical Guidance – Complimentary genetic counselling session to interpret your PALB2 result with a DHA‑licensed oncology expert.
- ✓Direct Billing Verification – WhatsApp +971 54 548 8731 for instant insurance pre‑authorisation and coverage confirmation.
ملخص تنفيذي
اختبار PALB2 الجيني لتقييم القابلية الوراثية للإصابة بسرطان البنكرياس من النوع الثالث، باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS)، مع دقة تشخيصية 99.9% وخدمة سحب منزلي معتمدة، ودعم إرشاد وراثي بعد التحليل، وفقًا لتشريعات دولة الإمارات العربية المتحدة.
Test Overview & Clinical Benchmarking
The PALB2 (Partner and Localizer of BRCA2) gene is a critical guardian against pancreatic, breast, and ovarian malignancies. This Genetic Test screens for pathogenic variants in the entire coding region of PALB2, determining your inherited susceptibility to pancreatic cancer type 3. يكتشف تحليل PALB2 الطفرات الوراثية المرتبطة بسرطان البنكرياس بدقة تتجاوز الطرق التقليدية.
| Feature | Our PALB2 NGS Test | Closest Alternative (Single‑Gene PCR) |
|---|---|---|
| Technology | Next Generation Sequencing (NGS) – full gene analysis | Targeted PCR/ Sanger sequencing – limited known mutations |
| Detection Rate | >99.9% sensitivity for all pathogenic variants | Misses novel or rare variants; ~80% coverage |
| Turnaround Time | 3–4 Weeks (rigorous quality checks) | 2–3 Weeks |
| Report Depth | Includes VUS interpretation, ACMG classification | Only yes/no for common mutations |
| DHA Compliance | Facility License 9834453, ISO 9001:2015 | May not be UAE‑licensed |
| Price | 2800 AED | ~1500–2200 AED (variable) |
Physician Insight & Safety Protocol
“As a clinical oncologist, I want you to know that a PALB2 result is a powerful piece of your health puzzle — it must be woven together with your personal and family history. A positive finding does not mean you will definitely develop cancer, but it empowers us to create a surveillance or prevention plan. Always discuss your results with a specialist who can translate them into actionable clinical decisions.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Medication Warning
Do not discontinue any prescribed medication, including hormonal therapies or chemoprevention agents, without consulting your treating physician.
Exclusion Criteria & Emergency Red Flags
- • Individuals unable to provide informed consent (including minors without court‑approved guardian consent per CDS Law 2026).
- • Patients with an active, untreated malignancy where immediate therapeutic decisions take precedence over susceptibility testing.
- • Pregnant women without a clear genetic counselling indication and specialist referral.
- ER Red Flag: If you suddenly develop jaundice, excruciating upper abdominal pain, or rapid unintentional weight loss, proceed to the nearest emergency department — do not wait for test results.
Frequently Asked Questions
Who should consider this PALB2 genetic test?
يُنصح بإجراء تحليل PALB2 للأشخاص الذين لديهم تاريخ عائلي لسرطان البنكرياس أو الثدي أو المبيض، خاصة إذا ظهرت إصابات في أقارب من الدرجة الأولى.
Individuals with a personal or family history of pancreatic, breast, or ovarian cancer, particularly when multiple first‑degree relatives are affected, or those with a known PALB2 variant in the family, should undergo testing. It is also appropriate for healthy individuals seeking a comprehensive cancer risk assessment under genetic counselling guidance.
How is the sample collected, and is it painful?
يتم جمع العينة عبر خدمة سحب الدم المنزلي المعتمدة، حيث يمكن استخدام الدم الكامل أو بطاقة FTA بنقرة إصبع واحدة دون ألم يُذكر.
Our DHA‑licensed phlebotomist arrives at your doorstep (8 AM‑11 PM) and collects either a standard venous blood sample or a single drop of blood on a specially designed FTA card. The process is virtually painless and takes under five minutes. Samples are transported in validated cold‑chain containers to our NGS facility.
What should I expect after receiving my PALB2 result?
بعد استلام النتائج، ستتلقى جلسة إرشاد وراثي هاتفية مع أخصائي لتفسير المخاطر ووضع خطة مراقبة أو وقاية شخصية.
A positive result triggers an immediate telephonic genetic counselling appointment with Dr. Reddy’s team. You will receive a detailed report describing the specific variant, its ACMG classification, and clinical management recommendations (e.g., enhanced pancreatic imaging, prophylactic considerations). Negative or variant‑of‑uncertain‑significance results are also explained in plain language to guide your ongoing care.
Regulatory & Quality Assurance
This strictly complies with Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic data protection, the CDS Law 2026 for minor consent, and the UAE PDPL. Our facility operates under DHA license 9834453 and ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139), guaranteeing analytical validity and patient privacy.
For insurance verification or home collection scheduling, contact us via WhatsApp at +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians